Study: KRIYA-825-901 Observe Study
Protocol Name: A Multicenter, Observational Study in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (OBSERVE)
The OBSERVE Study is a 2-part multicenter observational study to assess ocular images collected from participants diagnosed with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The duration of observation is 6 months (Part 1) or 18 months (Part 2).
No treatment or experimental intervention will be given in this study. In both Part 1 and Part 2, longitudinal GA progression will be evaluated from ocular imaging and ophthalmic assessments. Participants of Part 1 who are suitable for Part 2 will be invited to participate in Part 2, where further ocular images and ophthalmic will be collected through 18 months.
Principal Investigator: Dr Fred Chen
You may visit Clinical Trial Registry at ANZCTR – Registration for more information regarding The OBSERVE Study. To enquire further about this study, please contact the Clinical Trials Office on (08) 9381 0750, or email lionsvisiontrials@lei.org.au